Improvement of the immunogenicity of porcine circovirus type 2 DNA vaccine by recombinant ORF2 gene and CpG motifs

Viral Immunology

Volumn 28, Issue 5, 2015, Pages 290-296

  Li, Jun ^a   Shi, Jian Li ^a   Wu, Xiao Yan ^a   Fu, Fang ^b   Yu, Jiang ^a   Yuan, Xiao Yuan ^a   Peng, Zhe ^a   Cong, Xiao Yan ^a   Xu, Shao Jian ^a   Sun, Wen Bo ^a   Cheng, Kai Hui ^a   Du, Yi Jun ^a   Wu, Jia Qiang ^a   Wang, Jin Bao ^a   Huang, Bao Hua ^a  

^a SHANDONG PEANUT RESEARCH INSTITUTE   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CD3 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; DNA VACCINE; INTERLEUKIN 2; CPG-OLIGONUCLEOTIDE; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CELLULAR IMMUNITY; CONTROL GROUP; CONTROLLED STUDY; EXPERIMENTAL PIG; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PORCINE CIRCOVIRUS 2; RECOMBINANT GENE; RECTUM TEMPERATURE; VACCINATION; VIREMIA; ANIMAL; ANTIBODY PRODUCTION; BLOOD; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; CYTOTOXIC T LYMPHOCYTE; GENETICS; HELPER CELL; IMMUNOLOGY; PIG; RANDOMIZATION; SWINE DISEASES; VETERINARY;

ANIMALIA; PORCINE CIRCOVIRUS 2; SUIDAE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INTERLEUKIN-2; OLIGODEOXYRIBONUCLEOTIDES; OPEN READING FRAMES; RANDOM ALLOCATION; SWINE; SWINE DISEASES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION; VACCINES, DNA; VIRAL VACCINES; VIREMIA;

EID: 84930850526     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0121     Document Type: Article

References (33)

1. Allan G, Mcneilly F, Meehan B, et al. Isolation and characterisation of circoviruses from pigs with wasting syndromes in Spain, Denmark and Northern Ireland. Vet Microbiol 1999;66:115-123.
2. Allan G, McNeilly F, Kennedy S, et al. Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the USA and Europe. J Vet Diagn Invest 1998;10:3.
3. Allan G, Meehan B, Todd D, et al. Novel porcine circo-viruses from pigs with wasting disease syndromes. Vet Recb 1998;142:467.
4. Allan G, Kennedy S, Mcneilly F, et al. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol 1999;121:1-11.
5. Allan G, McNeilly F, Ellis J, et al. Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication. Arch Virol 2000;145:2421-2429.
6. Blanchard P, Mahe D, Cariolet R, et al. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 2003;21:4565-4575.
7. Cheung A, and Bolin S. Kinetics of porcine circovirus type 2 replication. Arch Virol 2002;147:43-58.
8. Cheng K, Li J, Yu Z, et al. Construction of a series of porcine circovirus DNA vaccine containing CpG motifs. Chin Vet Sci 2008;32:1055-1059.
9. Davis H. Use of CpG DNA for enhancing specific immune responses. Curr Top Microbiol 2000;247:171.
10. Fischer L, Barzu S, Andreoni C, et al. DNA vaccination of neonate piglets in the face of maternal immunity induces humoral memory and protection against a virulent pseu-dorabies virus challenge. Vaccine 2003;21:1732-1741.
11. Fu F, Li X, Lang Y, et al. Co-expression of Ubiquitin gene and capsid protein gene enhances the potency of DNA immunization of PCV2 in mice. Virol 2011;8:264.
12. Fenaux M, Opriessnig T, Halbur PG, et al. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J Virol 2004;78:6297-6303.
13. Fenaux M, Halbur P, Haqshenas G, et al. Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions. J Virol 2002;76:541.
14. Gurunathan S, Klinman DM, and Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000;18:927-974.
15. Ju C, Fan H, Tan Y, et al. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Vet Microbiol 2005; 109:179-190.
16. Kamstrup S, Barfoed AM, Frimann TH, et al. Immunisation against PCV2 structural protein by DNA vaccination of mice. Vaccine 2004;22:1358-1361.
17. Kiupel M, Stevenson GW, Galbreath EJ, et al. Porcine circovirus type 2 (PCV2) causes apoptosis in experimentally inoculated BALB/c mice. BMC Vet Res 2005;1:1-8.
18. Klinman DM, Yamshchikov G, and Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997;158:3635-3639.
19. Krieg AM. The role of CpG motifs in innate immunity. Curr Opin Immunol 2000;12:35-43.
20. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002;20:709-760.
21. Krieg AM. CpG motifs: the active ingredient in bacterial extracts. Nat Med 2003;9:831-835.
22. Kojima Y, Xin KQ, Ooki T, et al. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine 2002; 20:2857-2865.
23. Krieg AM, Wu T, Weeratna R, et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A 1998;95:12631.
24. Liu C, Lu Y, Zhang C, et al. cDNA, genomic sequence cloning and overexpression of ribosomal protein gene L9 (rpL9) of the giant panda (Ailuropoda melanoleuca). Chin Pre Vet Med 2005;6:123-126.
25. Li J, Yuan X, Zhang C, et al. A mouse model to study infection against porcine circovirus type 2: viral distribution and lesions in mouse. Virol J 2010;7:158.
26. Mcneilly F, McNair I, Mackie D, et al. Production, characterisation and applications of monoclonal antibodies to porcine circovirus 2. Arch Virol 2001;146:909-922.
27. Malek TR, and Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004;4:665-674.
28. Nawagitgul P, Morozov I, Bolin SR, et al. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J Gen Virol 2000;81:2281.
29. Pogranichnyy RM, Yoon KJIN, Harms PA, et al. Characterization of immune response of young pigs to porcine circovirus type 2 infection. Viral Immunol 2000;13:143-153.
30. Siegrist CA, Barrios C, Martinez X, et al. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur J Immunol 1998;28:4138-4148.
31. Sren K, Danila V, and Dennis M. Response of porcine peripheral blood mononuclear cells to CpG-containing oligodexynucleotides. Vet Microbiol 2001;78:353-362.
32. Shen HG, Zhou JY, Huang ZY, et al. Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccinesinmice.JGen Virol 2008;89:1857.
33. Tischer I, Gelderblom H, Vettermann W, et al. A very small porcine virus with circular single-stranded DNA. Nature 1982;295:64-66.